Dr Fouad George Azzam, MD | |
7101 Northland Cir N, Suite 209, Brooklyn Park, MN 55428-1517 | |
(763) 531-2030 | |
(763) 531-2099 |
Full Name | Dr Fouad George Azzam |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 7101 Northland Cir N, Brooklyn Park, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033185830 | NPI | - | NPPES |
067568700 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 20093 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Fouad George Azzam, MD 7101 Northland Cir N, Suite 209, Brooklyn Park, MN 55428-1517 Ph: (763) 531-2030 | Dr Fouad George Azzam, MD 7101 Northland Cir N, Suite 209, Brooklyn Park, MN 55428-1517 Ph: (763) 531-2030 |
News Archive
A new study published by researchers at SUNY Downstate Medical Center's School of Public Health assesses mercury levels in pregnant women and examines dietary and environmental sources of exposure to mercury. The research, which focuses on an urban immigrant community, examined risk factors that may be associated with elevated mercury levels, measured through urine and cord blood samples.
If you need dialysis for advanced kidney disease, where you get it could make a big difference. A large study found that patients in certain large chain facilities are significantly more likely to die than those treated elsewhere. Mortality was also higher in for-profit than non-profit dialysis centers.
As co-ordinator of the European project ‘ReBioStent', Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the European Union.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
Now, a new Israeli study published on the preprint server bioRxiv in June 2020 reports a new recombinant vaccine expressing the S or spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be highly protective with a single dose in an animal model. This could be a gamechanger in the fight to contain the outbreak.
› Verified 9 days ago
Kerry M Sheets, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7650 Zane Ave N, Brooklyn Park, MN 55443 Phone: 612-873-6963 | |
Dr. Arvin Mangasi Vocal, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10000 Zane Ave N, Brooklyn Park, MN 55443 Phone: 763-528-6999 Fax: 763-569-6208 | |
Dr. Melody Mendiola, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9300 Noble Pkwy N, Brooklyn Park, MN 55443 Phone: 763-236-5300 Fax: 763-236-5250 | |
Dr. Amy M. Putnam, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10000 Zane Ave N, Brooklyn Park, MN 55443 Phone: 763-572-5710 Fax: 763-569-6200 | |
Dr. Tajudeen Oladapo Fawole, M. D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4808 85th Ave N, Brooklyn Park, MN 55443 Phone: 763-496-1562 Fax: 763-657-0581 |